Hepatocellular Carcinoma

Oxidative stress and altered gene expression occurs in a metabolic liver disease model

A team of researchers under the direction of Dr. Jeffrey Teckman in the Department of Pediatrics at St. Louis University, have demonstrated that oxidative stress occurs in a genetic model of alpha-1-antitrypsin deficiency. ...

Medical research created Oct 30, 2012 | popularity not rated yet | comments 0

Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection

Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Op ...

Diseases, Conditions, Syndromes created Oct 22, 2012 | popularity 5 / 5 (1) | comments 0

A novel oncogenic network specific to liver cancer initiation

Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, ...

Cancer created Oct 07, 2012 | popularity not rated yet | comments 0 | with audio podcast

Blocking tumor-induced inflammation impacts cancer development

Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their ...

Cancer created Oct 03, 2012 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Swim training plus healthy diet factor in cancer fight: study

A new study just published in the journal Applied Physiology, Nutrition, and Metabolism (APNM) reaffirms the crucial role exercise along with good nutrition play in maintaining health and fighting disease.

Health created Sep 10, 2012 | popularity not rated yet | comments 0

New collaboration to develop treatments for liver disease

A new collaboration based at the University of Cambridge will aim to discover and develop new medicines to treat liver disease.

Diseases, Conditions, Syndromes created Sep 07, 2012 | popularity not rated yet | comments 0

Telaprevir: Added benefit in certain patients with hepatitis C

The drug telaprevir (trade name: Incivo) has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for ...

Diseases, Conditions, Syndromes created Sep 05, 2012 | popularity not rated yet | comments 0

New research sheds light on the molecular mechanisms by which a virus contributes to cancer

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide and is associated with exposure to hepatitis B virus (HBV). Patients carrying the virus have a 100-fold greater risk of ...

Cancer created Aug 29, 2012 | popularity 5 / 5 (3) | comments 0

Liver cancer cells stop making glucose as they become cancerous

As liver cancer develops, tumor cells lose the ability to produce and release glucose into the bloodstream, a key function of healthy liver cells for maintaining needed blood-sugar levels.

Cancer created Jul 30, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

miR-122: Loss of tiny liver molecule might lead to liver cancer

A new study shows that loss of a small RNA molecule in liver cells might cause liver cancer and that restoring the molecule might slow tumor growth and offer a new way to treat the disease.

Medical research created Jul 23, 2012 | popularity not rated yet | comments 0 | with audio podcast

Hepatitis C may increase deaths from both liver-related and other diseases

[EMBARGOED FOR JULY 18, 2012] In a long-term study of people infected with the hepatitis C virus (HCV), researchers found increased deaths from both liver-related and non-liver related diseases in patients with active infections ...

Diseases, Conditions, Syndromes created Jul 18, 2012 | popularity not rated yet | comments 0

Deadly liver cancer may be triggered by cells changing identity, study shows

A rare type of cancer thought to derive from cells in the bile ducts of the liver may actually develop when one type of liver cell morphs into a totally different type, a process scientists used to consider all but impossible. ...

Cancer created Jul 16, 2012 | popularity not rated yet | comments 0 | with audio podcast

Liver stiffness predicts liver failure, cancer and mortality in cirrhotic patients

Researchers from Spain established that liver stiffness, measured by transient elastography (TE), is an independent predictor of liver failure, hepatocellular carcinoma (HCC), and mortality in cirrhotic patients coinfected ...

Diseases, Conditions, Syndromes created Jul 10, 2012 | popularity not rated yet | comments 0

Scientists develop mouse model that could lead to new therapies for liver cancer

Researchers have created the first mouse model demonstrating the role of a cancer promoting gene, Astrocyte elevated gene-1 (AEG-1), in hepatocellular carcinoma, or liver cancer. The mouse model represents a critical step ...

Cancer created Jul 06, 2012 | popularity not rated yet | comments 0

Scientists unravel mechanism that causes liver cancer

Scientists at the Genome Institute of Singapore (GIS) have unraveled the mechanism that causes liver cancer (hepatocellular carcinoma, HCC), one of the most common solid tumors worldwide. This genome-wide research was done ...

Genetics created May 28, 2012 | popularity 5 / 5 (1) | comments 0


Hepatocellular carcinoma (HCC, also called malignant hepatoma) is the most common type of liver cancer. Most cases of HCC are secondary to either a viral hepatitide infection (hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis).

Compared to other cancers, HCC is quite a rare tumor in the United States. In countries where hepatitis is not endemic, most malignant cancers in the liver are not primary HCC but metastasis (spread) of cancer from elsewhere in the body, e.g., the colon. Treatment options of HCC and prognosis are dependent on many factors but especially on tumor size and staging. Tumor grade is also important. High-grade tumors will have a poor prognosis, while low-grade tumors may go unnoticed for many years, as is the case in many other organs, such as the breast, where a ductal carcinoma in situ (or a lobular carcinoma in situ) may be present without any clinical signs and without correlate on routine imaging tests, although in some occasions it may be detected on more specialized imaging studies like MR mammography.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Vicious cycle: Obesity sustained by changes in brain biochemistry

With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...

White matter imaging provides insight into human and chimpanzee aging

(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.